Exploring how metabolic profiles relate to chronic diseases and tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between metabolic disorders and the development of chronic diseases and tumors. It aims to identify common risk factors and explore the mechanisms by which metabolic status influences the occurrence of these conditions. By analyzing metabolic indexes in adults, the study seeks to provide insights into how metabolic health may contribute to chronic disease progression and cancer risk. The research will involve health screenings to gather relevant data from participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adult aged ≥18 years old
* Completed health screening

Exclusion Criteria:

* aged \<18 years old
* pregnancy

Where it's running

• The First Branch of the Affiliated Hospital of Chongqing Medical University
  Chongqing, Chongqing Municipality, China Recruiting

Study contacts

• Study coordinator: Qin Duan, doctor
• Email: 570549500@qq.com
• Phone: +8618623349865

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registering medical data and care outcomes for ALS, SMA, and other motor disorders

  This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.

  Recruiting Ambulanzpartner Soziotechnologie APST GmbH · Berlin, State of Berlin · NCT07900672

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions

  This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.

  Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07547098

• Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study

  This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.

  Recruiting KK Women's and Children's Hospital · Singapore, Singapore · NCT07534670

• Measuring how well patients follow daily oral medicines in Necker’s inherited metabolic diseases department

  This project will measure how well children, adolescents, and young adults with inherited metabolic diseases at Necker follow their daily oral medicines to see if a medication-education workshop is needed.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07356557

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.